Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia

Clinical trial NCT04712851 · RECRUITING

Trial details

NCT number: NCT04712851
Sponsor: Jonsson Comprehensive Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Intraepithelial Neoplasia Cervical Squamous Cell Carcinoma In Situ Cervical Squamous Intraepithelial Neoplasia 2

Start date: 2021-06-30
Primary completion: 2027-01-31
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.